Icon Legend

Browse by Speaker

Home
Browse by Speaker

Browse by Speaker

Type here to filter the list

S
Sabbagh, Mark

Mass General Brigham

(I012) Unexpected Detection of Viral Nucleic Acid in Targeted RNA-based Next Generation Sequencing Fusion Assays for Clinical Oncology
Location: 211 - 214, Level 2

Mark Sabbagh

Sah, Manoj Kumar

Texas Health Harris Methodist Hospital

(ID008) Multiplex Fragment Analysis Quickly Detects and Differentiates Non-tuberculous Mycobacterial Subspecies
Location: 301 - 305, Level 3

Manoj Kumar Sah

Samuel, Linoj

Henry Ford Health

Multiplex Infectious Disease Molecular Panels: Technology and Challenges
Location: 211 - 214, Level 2

Linoj Samuel

Sandhu, Manbir

DNAnexus

Unlocking Cancer Insights: Advanced Tertiary Analysis with DNAnexus and Intelliseq
Location: 202 - 204, Level 2

Manbir Sandhu

Sathyanarayana, Shiva

OGM in Action: Transformative Insights in Sarcomas, Lymphomas, and More
Location: 215 & 216, Level 2

Shiva Sathyanarayana

Sathyanarayana, Shivaprasad

Dartmouth-Hitchcock Medical Center

Analytics, Informatics, AI and the Expanding Role of the Clinical Laboratorian
Location: 118 - 120, Level 1

Shivaprasad Sathyanarayana

Saunders, Lauren

Ceres Nanosciences

Taking Sample Preparation to the Next Level by not Leaving Anything Important Behind
Location: 110, Level 1

Lauren Saunders

Schmidt, Ryan

Children's Hospital Los Angeles/Keck School of Medicine of USC

AMP Clinical Bioinformatician Body of Knowledge
Location: 211 - 214, Level 2

Ryan Schmidt

Schmitt, Anthony

Arima Genomics

Aventa FusionPlus: The 3D Genomics Solution to Diagnostic Dilemmas in Solid Tumors
Location: 221 & 222, Level 2

Anthony Schmitt

Scott, Stuart

Stanford

AMP/ACMG/CPIC/CAP/DPWG/ESPT/PharmGKB/PharmVar DPYD Genotyping Recommendations
Location: 220 - 222, Level 2

Stuart Scott

Disparities in Genetic Testing
Location: 211 - 214, Level 2

Stuart Scott

Platform Presentations of Selected Genetics Abstracts
Location: 109 & 110, Level 1

Stuart Scott

Role of Gender Identification in Genetic Testing
Location: 109 & 110, Level 1

Stuart Scott

Sedlazeck, Fritz

Baylor College of Medicine

Long Read Sequencing: The Long and Short of It.
Location: 109 & 110, Level 1

Fritz Sedlazeck

Shaker, Nada

University of California San Francisco, UCSF

Standardization Efforts for AI
Location: 118 - 120, Level 1

Nada Shaker

Shaknovich, Rita

Shaknovich Consulting LLC

cfDNA in Early Detection of Hematologic malignancies
Location: 118 - 120, Level 1

Rita Shaknovich

Shankar, Nakul

University of Colorado Anschutz Medical Campus

Multimodal Approach for the Diagnosis of Placental Mesenchymal Dysplasia
Location: 301 - 305, Level 3

Nakul Shankar

Shao, Lina

Advancing Solid Tumor Analysis: Integrating Chromosomal Microarray and Hotspot Mutation Analysis for Enhanced Diagnosis and Prognosis
Location: 110, Level 1

Lina Shao

Sheffield, Brandon

William Osler Health System

Optimising Outcomes in NSCLC: ctDNA Genotyping and Ultra-Fast NGS for Timely and Comprehensive Biomarker Testing at Diagnosis and at Progression
Location: 217 - 219, Level 2

Brandon Sheffield

Shen, Wei

Mayo Clinic

Incidental Detection of Acquired Variants in Germline Genetic Testing
Location: 109 & 110, Level 1

Wei Shen

Shiller, Michelle

Baylor Scott & White Health

Biomarker Testing in Metastatic Colorectal Cancer: BRAF Mutation Implications
Location: 215 & 216, Level 2

Michelle Shiller

Shiller, Shirley

PathGroup

Precision Pathways: Optimizing Testing Workflows for Patients with NSCLC
Location: 109, Level 1

Shirley Shiller

Sidiropoulos, Nikoletta

University of Vermont Medical Center

A Panel Discussion on Challenges and Practice Gaps Affecting Implementation of Oncology Precision Medicine
Location: 212 & 213, Level 2

Nikoletta Sidiropoulos

Siegmund, Stephanie

Harvard Medical School / Brigham & Women's Hospital

Role of Gender Identification in Genetic Testing
Location: 109 & 110, Level 1

Stephanie Siegmund

Silcox, Christina

Duke-Margolis Institute of Health Policy

Crafting the Blueprint: Standards Building and Policymaking for Clinical AI
Location: 118 - 120, Level 1

Christina Silcox

Silverman, Ian

The Importance of Allele-Specific Copy Number Analysis in Characterizing Response to Synthetic Lethal Agents
Location: 119 & 120, Level 1

Ian Silverman

Singh, Poorva

University of Minnesota

Novel FANCD2 Variant Leading to Somatic Rescue in a Patient With Fanconi Anemia
Location: 301 - 305, Level 3

Poorva Singh

Sirohi, Deepika

University of California San Francisco

Case Studies in Solid Tumors I
Location: 211 - 214, Level 2

Deepika Sirohi

Human Tumor Atlas Network: Mapping Tumor Transitions at Molecular Resolution
Location: Ballroom, Level 1

Deepika Sirohi

Platform Presentations of Selected Solid Tumors Abstracts
Location: 109 & 110, Level 1

Deepika Sirohi

Whole Exome Sequencing in Solid Tumors - the Changing Paradigm of Clinical Oncology
Location: 220 - 222, Level 2

Deepika Sirohi

Skaugen, John

University of Pittsburgh School of Medicine

Whole Exome Sequencing in Solid Tumors - the Changing Paradigm of Clinical Oncology
Location: 220 - 222, Level 2

John Skaugen

Slasinski, Jonathan

Empowering Molecular Pathology Research With Fast, Flexible Sequencing and High-Throughput Spatial Multiomics
Location: 109, Level 1

Jonathan Slasinski

Smithgall, Marie

Columbia University Medical Center

There’s a Fungus Among Us! Next-Generation Molecular Testing in Diagnostic Mycology
Location: 301 - 305, Level 3

Marie Smithgall

Snow, Anthony

University of Iowa Hospitals and Clinics

Continuing Challenges to Providing More Provider and Patient Friendly NGS Molecular Biomarker Reporting
Location: 220 - 222, Level 2

Anthony Snow

Soares, Dr. Luciano

The Quest for QC Perfection: Trials, Tribulations and Test Accuracy with Patient-Like Controls
Location: 111 & 112, Level 1

Dr. Luciano Soares

Soderquist, Craig

Columbia University

Advances in Characterizing Structural Chromosomal Alterations: Utility of Optical Genome Mapping and Long Read Sequencing in Hematopoietic Cancers and the Germline Genome
Location: 109 & 110, Level 1

Craig Soderquist

New Molecular Genomic Discoveries in B-Cell Neoplasms and Clinical Applications
Location: Ballroom, Level 1

Craig Soderquist

Platform Presentations of Selected Hemepath Abstracts
Location: 211 - 214, Level 2

Craig Soderquist

Utilization of Cell Free DNA in Characterization and Detection of Minimal Residual Disease in Lymphoid Malignancies
Location: 118 - 120, Level 1

Craig Soderquist

SoRelle, Jeffrey

UT Southwestern

AMP/CAP/NSGC Slice Testing—Considerations from Ordering to Reporting
Location: 301 - 305, Level 3

Jeffrey SoRelle

Meet the Authors: AMP/CAP/NSGC Slice Testing—Considerations from Ordering to Reporting
Location: Innovation Spotlight Stage #1

Jeffrey SoRelle

Sorger, Peter

Harvard Medical School

Human Tumor Atlas Network: Mapping Tumor Transitions at Molecular Resolution
Location: Ballroom, Level 1

Peter Sorger

Stachowiak, Matt

GenomOncology

Integrating Patient & Multi-Source Genomic Data into a Unified Clinical Care System at UAB, to Improve Research and Patient Care
Location: 221 & 222, Level 2

Matt Stachowiak

Precision Oncology in Action: NGS Workflows, Multi-Site Clinical Genomic Reporting, and Organization-Wide Integration at Atrium Health
Location: 221 & 222, Level 2

Matt Stachowiak

Starolis, Meghan

Quest Diagnostics

Multiplex Syndromic Panels: Challenges and Opportunities for Reimbursement
Location: 211 - 214, Level 2

Meghan Starolis

Starrett, Gabriel

National Cancer Institute

Mechanisms of Viral-Host Cell Interaction: Integration, Mutagenesis and Tumorigenesis
Location: 211 - 214, Level 2

Gabriel Starrett

Statz, Cara

Genomenon

Comprehensive Curated Content to Improve Detection and Reporting of Somatic and Germline Variants for WGS and Large Cancer Gene Panels
Location: 214, Level 2

Cara Statz

Stricker, Thomas

OneOncology

A Panel Discussion on Challenges and Practice Gaps Affecting Implementation of Oncology Precision Medicine
Location: 212 & 213, Level 2

Thomas Stricker

Stricker, Thomas

Tennessee Oncology

Strategic Collaborations for Expanding Liquid Biopsy Use Globally
Location: 214, Level 2

Thomas Stricker

Sukhadia, Shrey

DHMC

Bridging the Dimensions: Unleashing the Power of Deep Learning in Precision Medicine
Location: 220 - 222, Level 2

Shrey Sukhadia

(ST014) The Utilization of Whole Transcriptome Sequencing to Analyze Downstream Expression of Biologically Significant Transcripts of Potentially Oncogenic Fusion Products, for Clinical Practice
Location: 109 & 110, Level 1

Shrey Sukhadia

Sun, Lulu

Washington University in St. Louis School of Medicine

Curated Resource List for Training and Continuing Education in Molecular Pathology (A Special EdCoP Event)
Location: 109 & 110, Level 1

Lulu Sun

Curated Resource List for Training and Continuing Education in Molecular Pathology (A Special EdCoP Event)
Location: 109 & 110, Level 1

Lulu Sun

From Pathology to the Biobank: Considerations for Managing Laboratory Samples and Data
Location: 301 - 305, Level 3

Lulu Sun

Sura, Gloria

M.D. Anderson Cancer Center

Same-Day Molecular Testing Results from Cytology Specimens: The Next Frontier of Rapid On-Site Evaluation? Optimizing Small Biopsy Workflows with Idylla™
Location: 217 - 219, Level 2

Gloria Sura

Sworder, Brian

University of California, Irvine

Profiling Cell-Free DNA in Lymphoma: MRD and Beyond
Location: 118 - 120, Level 1

Brian Sworder

Szelinger, Szabolcs

The Sample Journey Through the OncoExTra® Tissue Genomic Profiling Test
Location: Innovation Spotlight Stage #1

Szabolcs Szelinger